WATKINS TIM (CMO & Head of Development) sold 3.61K shares of CONTINEUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $43.6K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/30/2025ACC: 0001437749-25-038938
Officer· CMO & Head of Development
Since Mar 2026
-3.61K
Net shares
Net seller
$43.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.61K acquired · 7.22K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
+3.61K
Price / share
$4.50
Trade value
$16.25K
% of position
New position
12/29/2025
0.00→3.61K
Class A Common Stock
Direct
Shares
−3.61K
Price / share
$12.06
Trade value
$43.56K
% of position
New position
12/29/2025
3.61K→0.00
Total
Net shares
+0.00
Net value
-$27.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 12/29/2025 | M · Option Exercise | +3.61K | $4.50 | $16.25K | New position | 0.00 | 3.61K |
| Class A Common Stock Direct | 12/29/2025 | S · Sale | −3.61K | $12.06 | $43.56K | New position | 3.61K | 0.00 |
| Total | +0.00 | -$27.31K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Class A Common Stock
3.61K shares
Shares
−3.61K
Strike price
4.50
Held after
256.39K
Exercisable
—
12/29/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Class A Common Stock3.61K shares | 12/29/2025 | M · Option Exercise | −3.61K | 4.50 | — | 256.39K |